Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report) was the target of a significant growth in short interest during the month of May. As of May 15th, there was short interest totaling 246 shares, a growth of ∞ from the April 30th total of 0 shares. Based on an average daily trading volume, of 186 shares, the days-to-cover ratio is presently 1.3 days.
Hikma Pharmaceuticals Stock Performance
Hikma Pharmaceuticals stock remained flat at $39.18 during mid-day trading on Monday. The company’s stock had a trading volume of 100 shares, compared to its average volume of 1,559. Hikma Pharmaceuticals has a twelve month low of $31.80 and a twelve month high of $56.91. The business has a 50 day simple moving average of $36.88 and a 200 day simple moving average of $39.42.
Hikma Pharmaceuticals Company Profile
Hikma Pharmaceuticals is a multinational pharmaceutical company founded in Amman, Jordan, in 1978. Headquartered in London, the company develops, manufactures and markets a broad range of branded and non-branded generic medicines, as well as speciality injectable products. Over four decades, Hikma has grown from a regional pharmaceutical supplier to a global healthcare provider, maintaining a focus on quality manufacturing and regulatory compliance.
The company operates across three core business segments: branded generics, speciality injectables and non-branded generics.
Recommended Stories
- Five stocks we like better than Hikma Pharmaceuticals
- Braze Blazes Ahead on Q1 2027 Earnings Beat, Raised Guidance
- Are the 3 Newest Members of the $1 Trillion Market Cap Club the Latest Sign of an AI Bubble?
- Was Hormel’s Q2 Earnings Report the Turnaround Investors Needed?
- 3 Active ETFs to Ride the Hands-On Management Trend
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
